ARPITA THAKORE: Open Payments
NPI 1912578998 · VINELAND, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$469 in 26 payments from 15 companies in 2025. Trend: 2023 $71 · 2024 $1,010 · 2025 $469
Food & beverage: $469
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 4 | $81 |
| Astellas Pharma US Inc | 3 | $61 |
| AstraZeneca Pharmaceuticals LP | 3 | $52 |
| Gilead Sciences, Inc. | 2 | $37 |
| Janssen Biotech, Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 2 | $36 |
| E.R. Squibb & Sons, L.L.C. | 2 | $32 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $22 |
| GlaxoSmithKline, LLC. | 1 | $21 |
| Eisai Inc. | 1 | $20 |
Products named: ENHERTU, Padcev, Trodelvy, TECVAYLI, KEYTRUDA, INJECTAFER, OPDIVO, DATROWAY.
Industry payments across NJ — which companies pay providers there.
